New research centre to advance diabetes treatment

A new centre for research to develop a new generation of medicines that will transform the lives of people living with diabetes has opened in Oxford.

Public Health England expects the number of people with diabetes to increase in the next two decades from 3.9 million people in 2017 to 4.9 million in 2035. In light of these predictions, the new centre, collaborating with the University of Oxford, will carry out new research on new medicines to treat diabetes, understanding the relationship between insulin resistance and other health conditions and analysing complex data to earlier detect Type 2 diabetes.

Business Secretary Greg Clark, who attended the opening of the Novo Nordisk Research Centre, said: “This centre has the potential to transform the way diabetes is treated in the future and improve the lives of people around the world. Our universities and research institutes are world beating and this international investment in the UK is a vote of confidence in both the talent we have and the quality of research and products our scientists develop. This is our modern Industrial Strategy in action as we strive towards more public and private research and development investment to upgrade our economy and build a Britain fit for the future.”

Novo Nordisk will invest around £115 million over a period of 10 years and the new centre will mean up to 100 research jobs in the coming years.

Event Diary

Safety & Health Expo is the UK’s largest event for the health and safety sector, helping 13,000+ global professionals source innovative solutions across occupational health, wellbeing, PPE and more.